Skip to main content
. Author manuscript; available in PMC: 2022 Feb 6.
Published in final edited form as: Cancer Prev Res (Phila). 2021 Apr 23;14(7):729–740. doi: 10.1158/1940-6207.CAPR-20-0303

Figure 2.

Figure 2.

ROC curves. A. Top 3 miRNA markers in the TexGen cohort comparing stage II vs. control. B. miRNA marker panels in combination with CA 19–9 in TexGen cohort comparing stage II vs. control. C. miRNA markers in the UPMC cohort comparing stage II vs. control. D. miRNA marker panels in combination with CA 19–9 in the UPMC cohort comparing stage II vs. control. E. miRNA markers in the EDRN cohort comparing stages I & II vs. control. F. miRNA marker panels in combination with CA 19–9 in the EDRN cohort comparing stages I & II vs. control.